10 research outputs found
Assessment of variation in the alberta context tool: the contribution of unit level contextual factors and specialty in Canadian pediatric acute care settings
Background: There are few validated measures of organizational context and none that we located are
parsimonious and address modifiable characteristics of context. The Alberta Context Tool (ACT) was developed to
meet this need. The instrument assesses 8 dimensions of context, which comprise 10 concepts. The purpose of
this paper is to report evidence to further the validity argument for ACT. The specific objectives of this paper are
to: (1) examine the extent to which the 10 ACT concepts discriminate between patient care units and (2) identify
variables that significantly contribute to between-unit variation for each of the 10 concepts.
Methods: 859 professional nurses (844 valid responses) working in medical, surgical and critical care units of 8
Canadian pediatric hospitals completed the ACT. A random intercept, fixed effects hierarchical linear modeling
(HLM) strategy was used to quantify and explain variance in the 10 ACT concepts to establish the ACT’s ability to
discriminate between units. We ran 40 models (a series of 4 models for each of the 10 concepts) in which we
systematically assessed the unique contribution (i.e., error variance reduction) of different variables to between-unit
variation. First, we constructed a null model in which we quantified the variance overall, in each of the concepts.
Then we controlled for the contribution of individual level variables (Model 1). In Model 2, we assessed the
contribution of practice specialty (medical, surgical, critical care) to variation since it was central to construction of
the sampling frame for the study. Finally, we assessed the contribution of additional unit level variables (Model 3).
Results: The null model (unadjusted baseline HLM model) established that there was significant variation between
units in each of the 10 ACT concepts (i.e., discrimination between units). When we controlled for individual
characteristics, significant variation in the 10 concepts remained. Assessment of the contribution of specialty to
between-unit variation enabled us to explain more variance (1.19% to 16.73%) in 6 of the 10 ACT concepts. Finally,
when we assessed the unique contribution of the unit level variables available to us, we were able to explain
additional variance (15.91% to 73.25%) in 7 of the 10 ACT concepts.
Conclusion: The findings reported here represent the third published argument for validity of the ACT and adds
to the evidence supporting its use to discriminate patient care units by all 10 contextual factors. We found
evidence of relationships between a variety of individual and unit-level variables that explained much of this
between-unit variation for each of the 10 ACT concepts. Future research will include examination of the
relationships between the ACT’s contextual factors and research utilization by nurses and ultimately the
relationships between context, research utilization, and outcomes for patients
The Urine Circulating Cathodic Antigen (CCA) Dipstick: A Valid Substitute for Microscopy for Mapping and Point-Of-Care Diagnosis of Intestinal Schistosomiasis
BACKGROUND
The World Health Organization now recommends the provision of praziquantel treatment to preschool-aged children infected with schistosomiasis. For intestinal schistosomiasis the current operational field diagnostic standard is examination of a thick Kato-Katz smear by microscopy prepared from a single stool specimen, and although pragmatic, this methodology has well-known shortcomings. Here, as a potential alternative, the performance of the urine circulating cathodic antigen (CCA) dipstick test was assessed in terms of disease-mapping and point-of-care diagnosis for intestinal schistosomiasis in preschool-aged children. Our manuscript reports on findings at baseline and at the end of a one-year longitudinal treatment study.
METHODOLOGY/PRINCIPAL FINDINGS
A total of 925 children (mean age 2.8 years) were initially recruited from six lakeshore villages representative of high, moderate and low levels of disease transmission. At baseline, all children were tested for intestinal schistosomiasis by microscopic examination of duplicate Kato-Katz smears prepared from a single stool faecal, by antigen detection with the urine CCA dipstick test and by serology with a commercially available ELISA test (as 'gold-standard') that measures host antibody titres to soluble egg antigens. As a point-of-care diagnosis, the urine CCA dipstick test achieved sensitivity and specificity values ranging from 52.5-63.2% and 57.7-75.6%, respectively, with faecal microscopy achieving very high specificities (>87%) but sensitivities as low as 16.7% in the low transmission setting.
CONCLUSION/SIGNIFICANCE
The urine CCA test was shown to be more effective than faecal microscopy especially in lower transmission settings. The diagnostic performance of this test was not significantly impacted by treatment history or co-infections with other intestinal helminths
Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
Background: The randomized, double-blind Multiple Outcomes of Raloxifene Evaluation (MORE) trial found that 4 years of raloxifene therapy decreased the incidence of invasive breast cancer among postmenopausal women with osteoporosis by 72% compared with placebo. We conducted the Continuing Outcomes Relevant to Evista (CORE) trial to examine the effect of 4 additional years of raloxifene therapy on the incidence of invasive breast cancer in women in MORE who agreed to continue in CORE. Methods: Women who had been randomly assigned to receive raloxifene (either 60 or 120 mg/day) in MORE were assigned to receive raloxifene (60 mg/day) in CORE (n = 3510), and women who had been assigned to receive placebo in MORE continued on placebo in CORE (n = 1703). Breast cancer incidence was analyzed by a log-rank test, and a Cox proportional hazards model was used to compute hazard ratios (HRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. Results: During the CORE trial, the 4-year incidences of invasive breast cancer and estrogen receptor (ER)-positive invasive breast cancer were reduced by 59% (HR = 0.41; 95% CI = 0.24 to 0.71) and 66% (HR = 0.34; 95% CI = 0.18 to 0.66), respectively, in the raloxifene group compared with the placebo group. There was no difference between the two groups in incidence of ER-negative invasive breast cancer during CORE (P = .86). Over the 8 years of both trials, the incidences of invasive breast cancer and ER-positive invasive breast cancer were reduced by 66% (HR = 0.34; 95 % CI = 0.22 to 0.50) and 76% (HR = 0.24; 95% CI = 0.15 to 0.40), respectively, in the raloxifene group compared with the placebo group. During the CORE trial, the relative risk of thromboembolism in the raloxifene group compared with that in the placebo group was 2.17 (95% CI = 0.83 to 5.70). This increased risk, also observed in the MORE trial, persisted over the 8 years of both trials. Conclusions: The reduction in invasive breast cancer incidence continues beyond 4 years of raloxifene treatment in postmenopausal women with osteoporosis. No new safety concerns related to raloxifene therapy were identified during CORE. © Oxford University Press 2004, all rights reserved
Flower Development
Flowers are the most complex structures of plants. Studies of Arabidopsis thaliana, which has typical eudicot flowers, have been fundamental in advancing the structural and molecular understanding of flower development. The main processes and stages of Arabidopsis flower development are summarized to provide a framework in which to interpret the detailed molecular genetic studies of genes assigned functions during flower development and is extended to recent genomics studies uncovering the key regulatory modules involved. Computational models have been used to study the concerted action and dynamics of the gene regulatory module that underlies patterning of the Arabidopsis inflorescence meristem and specification of the primordial cell types during early stages of flower development. This includes the gene combinations that specify sepal, petal, stamen and carpel identity, and genes that interact with them. As a dynamic gene regulatory network this module has been shown to converge to stable multigenic profiles that depend upon the overall network topology and are thus robust, which can explain the canalization of flower organ determination and the overall conservation of the basic flower plan among eudicots. Comparative and evolutionary approaches derived from Arabidopsis studies pave the way to studying the molecular basis of diverse floral morphologies